From a Skin Concern to a Clearer Understanding
Dermatology information is hard to evaluate because a single skin concern can be tied to multiple treatments, technologies, product names, and clinical approaches, often described differently depending on who’s telling you about them. A treatment is rarely defined by its name alone: the same concern can be tied to different procedures, devices, treatment settings or combinations of approaches, so we do not treat a procedure name as the full unit of information.
This page sets out our dermatology research method, including the treatment technology research method we use to look at what actually sits behind a treatment.
We don’t start with “which clinic is best.” We start with something more basic:
What are we actually looking at?
From there, we identify the skin concern, look into the treatments associated with it, examine the technology involved and how it’s applied, review whatever evidence exists, and then factor in patient and market information. In short: concern, treatment, technology, application, evidence, experience. That sequence is what lets us separate what a treatment is from how it’s delivered, what technology is involved, what’s actually known about it, and what people experience.
1. Define the Subject
The first step is figuring out exactly what we’re researching. That could be a skin concern, a treatment, a procedure, a device or technology, a treatment category, a Korean-language term, a pricing question, or a commonly discussed treatment combination.
When the starting point is a skin concern, we define the problem or objective in question: acne, acne scars, pigmentation, redness, uneven texture, enlarged pores, signs of aging, hair and scalp concerns, and so on. A single concern usually has more than one possible treatment approach, so we’re careful not to assume one procedure represents the whole market.
Terminology matters a lot here. A Korean commercial treatment name doesn’t always line up cleanly with a standardized medical term in English, so instead of relying on a translated name, we try to identify the actual treatment or technology underneath it.
2. Identify the Treatment
Once we know the subject, we pin down exactly what procedure is being discussed: a treatment category, an individual procedure, a branded name, a device-based procedure, an injectable, a combination treatment, or clinic-specific terminology. Then we look at the treatment itself: what it is, what it’s commonly meant to address, how providers describe it, the different versions or approaches out there, how it compares to related treatments, common combinations, and any real limitations or open questions.
Commercial names complicate this: different procedures can end up sounding alike, while genuinely similar procedures get marketed under different names. Where the terminology is ambiguous, we explain the distinction rather than quietly treating different terms as the same thing.
Provider descriptions are treated as provider information, not fact, unless something independent backs them up. A treatment being heavily marketed doesn’t tell you whether it actually works.
Classifying treatment terms
For research purposes, we sort treatments by how well we can actually establish what they are. Some terms are established terminology: recognized medical or technical terms with a fairly clear meaning. Others are commercial treatment names used by a specific clinic, provider, or manufacturer. Some describe device-based treatments built substantially around one piece of technology, and others are combination treatments spanning multiple procedures or modalities. Some are simply market terms: common in consumer or Korean-market discussion, but needing extra explanation to pin down their precise medical meaning. And some remain genuinely unclear or ambiguous, where the meaning can’t be reliably established from what’s available.
When a term stays ambiguous, we say so rather than quietly presenting a guess as settled fact.
3. Examine the Technology
Where technology or equipment is part of the picture, we look at what’s actually behind the treatment: laser wavelength or category, radiofrequency, ultrasound, light-based energy, thermal energy, other energy-based tools, microneedling systems, injectable materials and technologies, and similar equipment.
We keep two things separate: whether a technology exists, and whether there’s evidence it produces a particular clinical outcome. A device being available in Korea doesn’t mean it beats another device, and a newer technology isn’t automatically a better one. The goal isn’t to promote any particular device. It’s to explain what technology is actually being discussed, how it differs from related ones, and what evidence, if any, backs the claims made about it.
Separating the device from the treatment
A device isn’t a treatment outcome by itself. The same device can serve several purposes, and similar treatment goals can be reached through entirely different technologies. So we try to keep four things distinct: the device (the technology or equipment itself), the procedure (how it’s applied), the treatment objective (what it’s meant to address), and the clinical evidence (what actually supports the claims made about it).
Keeping these apart is what stops device marketing language from getting mistaken for independent clinical evidence.
Tracing a technology through to the market
Technology research follows its own path: from the technology itself, to the device, to the manufacturer, to how it’s applied in treatment, to the evidence, to how it’s actually used in the market. But none of those links should be assumed automatically: a manufacturer might describe a wide range of applications, a clinic might use the same device differently than intended, and evidence might exist for one application but not another. Each claim needs to be checked in its own context rather than inherited from the technology’s general reputation.
4. Review the Evidence
Evidence gets weighed separately from popularity, marketing, or patient experience. Depending on the subject, that might mean looking at scientific literature, clinical studies, professional sources and guidance, regulatory or public information, provider claims, or other identifiable evidence.
The strength of evidence varies a lot from one treatment to the next, so we don’t treat every source as equally reliable. When evidence is thin, mixed, indirect, or hard to pin down, we say so.
It’s also worth separating evidence about the general treatment category from evidence about a particular technology, a specific device, a specific protocol, or a specific combination. Evidence for one doesn’t automatically carry over to the others.
Evidence versus marketing claims
Dermatology writing tends to blend scientific terminology with promotional language, so it helps to be explicit about the difference between “this treatment is offered by many clinics” and “this treatment has demonstrated a particular clinical effect”: those are two different claims that need two different kinds of support.
The same logic applies elsewhere: popular doesn’t mean proven, new doesn’t mean superior, expensive doesn’t mean more effective, a manufacturer’s claim isn’t independent evidence, and a clinic’s treatment description isn’t a clinical guideline.
5. Investigate the Korean Market
After the treatment itself, we look at how it shows up in the Korean market: clinic websites, Korean-language search results, local terminology, publicly listed treatments, device names, session details, pricing, packages, consumer discussions, frequently mentioned procedures, and which treatment categories get promoted most.
This answers a different question: how is this treatment actually presented and talked about in Korea? Popularity here isn’t proof of effectiveness: a treatment can be popular because of marketing, accessibility, pricing, convenience, or plain consumer interest, not necessarily because it works better.
We flag what Korean clinic websites say as provider information, because that’s what it is. A clinic’s description of its own treatment isn’t independent evidence just because it’s published.
Treatment combinations
Combination treatment is a significant part of Korean dermatology: a single skin concern is often addressed with several procedures offered together, and the market frequently sells treatments as packages or sequences rather than standalone procedures. When that’s relevant, we look at which treatments are combined, what each component is meant to address, how clinics describe the combination, how often it’s offered, whether there’s actual evidence for the combination itself, whether it looks more like a market practice than an established clinical standard, and what limitations or open questions remain.
A combination being heavily marketed doesn’t mean it’s medically necessary or superior to treating each concern separately, and a combination showing up on a clinic’s menu doesn’t mean it’s medically appropriate for every patient who walks in.
6. Examine Patient Experience
Patient reports add practical, real-world context that clinical or provider sources often miss: things like the consultation, the appointment itself, communication, the treatment process, discomfort during treatment, wait times, staff interactions, downtime, recovery, repeat sessions, follow-up, pricing experience, overall satisfaction, and recurring complaints.
We treat these as experiences, not medical evidence that a treatment works clinically. One person’s outcome doesn’t tell you what another patient should expect, individual accounts can vary quite a bit depending on the clinic, the patient, and other circumstances that don’t necessarily generalize, and we’re careful not to treat online communities or review platforms as representative of every Korean dermatology patient.
7. Compare Related Treatments
When several treatments address the same concern, comparing them helps clarify the real differences. We avoid building a simple “best treatment” ranking and instead compare specific, identifiable attributes:
| Attribute | Research Question |
|---|---|
| Concern | What is the treatment commonly discussed for? |
| Treatment | What procedure is being performed? |
| Technology | What technology or modality is involved? |
| Application | How is the treatment described or applied? |
| Evidence | What evidence supports relevant claims? |
| Availability | How commonly is it publicly offered? |
| Price | What public pricing information is available? |
| Experience | What do patients report? |
| Limitations | What remains uncertain? |
The point isn’t to produce a universal ranking. It’s to make the meaningful differences easier to see, which gives a far more useful comparison than simply ranking treatments first to last.
8. Investigate Prices Separately
Pricing gets its own research pass because dermatology prices vary so much. Where we can, we record the source, date, price type, treatment, treatment area, number of sessions, package conditions, promotional terms, and any additional costs, and we distinguish between a published price, a promotional price, a patient-reported price, an estimated market range, and a quoted price.
Every price we publish carries its source and the date it was observed, and a price we cannot source and date is left out. A researched price is context, not a guaranteed quote.
9. Classify Information
Before anything gets published, we sort it by what it actually represents:
- Evidence: backed by scientific or professional sources
- Provider reported: stated by a clinic, doctor, or manufacturer
- Publicly confirmed: checkable against identifiable public or official sources
- Market information: publicly observable availability, pricing, terminology, or practices
- Patient reported: one person’s account of their own experience
- Editorial analysis: our own read on the sources gathered
Keeping these separate is what stops provider claims, patient stories, and actual evidence from getting flattened into the same thing.
10. Record Source and Date
Anything that can change over time gets tied to a source and an observation date wherever practical: prices, promotions, clinic services, doctors, equipment, treatment availability, and international patient services in particular. For device and treatment facts we give the source and, where it matters, the date.
The source tells us where the information came from. The date tells us when. Both matter once you’re dealing with information that doesn’t stay accurate for long.
11. Identify Uncertainty
Not everything can be independently verified, and when something’s uncertain, we don’t dress it up as more certain than it is. Depending on the situation, we’ll say things like “according to the provider,” “publicly available information indicates,” “patient-reported information suggests,” “multiple sources describe,” or “we were unable to independently confirm this.”
Flagging uncertainty is part of doing this properly, not something to hide.
12. Editorial Review
Before publication, we review research for source quality, factual consistency, classification, how current the dates are, unsupported claims, ambiguous terminology, medical overstatement, commercial influence, and any limitations that haven’t been made clear.
We also watch for language that quietly turns information into a medical recommendation. Words like “best,” “safest,” “most effective,” “guaranteed,” or “no downtime” need real support behind them. They don’t get to stand as established fact on their own. When an article already published falls short of these rules, we correct it, and figures we cannot trace to a source are removed rather than kept.
Our Research Record
Where it’s useful, our internal process keeps track of the following for a given piece of research:
| Field | Purpose |
|---|---|
| Source | Where the information came from |
| Source Type | Evidence, Provider, Public, Patient, Market, etc. |
| Date | When the information was observed |
| Verification Status | How independently it can be confirmed |
| Claim Type | What kind of statement is being made |
| Confidence | How strongly the information is supported |
| Limitation | What remains unknown or uncertain |
This lets us apply the same principles consistently across treatment, technology, clinic, price, and patient-experience content.
What We Don’t Assume
There are a handful of leaps our research process won’t let us make: that popular means effective, that expensive means better, that new means superior, that heavily reviewed means high quality, that clinic marketing counts as independent evidence, that one patient’s experience is the typical outcome, or that a treatment being available amounts to a medical recommendation.
On treatments and technology specifically, we won’t conclude that the treatment offered by the most clinics is medically superior, that a packaged combination is medically necessary, that positive reviews prove clinical effectiveness, or that a provider’s own claim counts as independent evidence.
Holding this line is central to how we read Korean dermatology information, and it matters most in a market where medical information and commercial promotion tend to show up wearing the same language.
Updating Research
Dermatology information doesn’t sit still: prices shift, promotions end, clinics update their treatment menus and add or drop equipment, doctors change affiliations, new devices enter the market, manufacturers release new versions, treatment names shift, consumer terminology keeps evolving, and the evidence itself keeps moving.
So for anything time-sensitive, we ask whether the source is still current and whether it’s due for another look. An older source isn’t necessarily wrong, but its age is worth factoring in when the underlying information changes quickly, and we do not assume a statement about a clinic’s equipment or treatment lineup stays accurate indefinitely.
The Result
Our process is built to go beyond a simple list of treatments. It connects a skin concern to the treatment, the technology behind it, the evidence available, the Korean market context, patient experience, and finally a comparison across options.
The point of this research method is not to tell readers which procedure to choose. It is to make the underlying information easier to understand: what the treatment actually is, what technology is involved, how it is described in Korea, what is backed by evidence versus what is simply a provider or market claim, how it compares to related treatments, what patients report, and what still is not settled. We use this research to provide context, not to replace individualized medical evaluation or professional medical advice.
Our job isn’t to turn information into certainty. It’s to make the information easier to understand.
To see this process applied to a single treatment, read our page on Rejuran pain level, which keeps patient descriptions, the limits of the pain research and platform pricing apart.